We are live on ! Find out more
CEMI

Chembio diagnostics, Inc.
CEMI

Delisted

CEMI was delisted on the 27th of April, 2023.

Back to rankings

38 hedge funds and large institutions have $44.2M invested in Chembio diagnostics, Inc. in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 8

19% more capital invested

Capital invested by funds: $37.3M → $44.2M (+$6.91M)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

3% less funds holding

Funds holding: 39 → 38 (-1)

Holders
38
Holders Change
-1
Holders Change %
-2.56%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
10
Reduced
8
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RC
Roubaix Capital
Colorado
+$1.1M
2
EIM
Essex Investment Management
Massachusetts
+$1.04M
3
BlackRock
BlackRock
New York
+$956K
4
NCM
Nantahala Capital Management
Connecticut
+$607K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$291K

Top Sellers

Rank Fund Capital Flow
1
MAG
Millrace Asset Group
Pennsylvania
-$527K
2
Deutsche Bank
Deutsche Bank
Germany
-$247K
3
Renaissance Technologies
Renaissance Technologies
New York
-$241K
4
PCM
Perkins Capital Management
Minnesota
-$198K
5
SIM
Spark Investment Management
New York
-$147K
Name Holding Trade Value Shares
Change 		Change in
Stake
LPL Financial
26
LPL Financial
California
$215K +$238K +35,337 New
Renaissance Technologies
27
Renaissance Technologies
New York
$210K -$241K -35,800 -51%
Deutsche Bank
28
Deutsche Bank
Germany
$205K -$247K -36,572 -52%
UBS Group
29
UBS Group
Switzerland
$162K +$17.7K +2,621 +11%
PFC
30
Phocas Financial Corp
California
$122K – – –
Squarepoint
31
Squarepoint
New York
$114K +$126K +18,707 New
HighTower Advisors
32
HighTower Advisors
Illinois
$90K +$99.9K +14,815 New
DLA
33
Douglas Lane & Associates
New York
$86K – – –
FM
34
Family Management
New York
$66K – – –
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$6K – – –
AG
36
Advisor Group
Arizona
$3K -$3.04K -450 -50%
LTFS
37
Ladenburg Thalmann Financial Services
Florida
$3K – – –
VFA
38
Valeo Financial Advisors
Indiana
$1K – – –
SIM
39
Spark Investment Management
New York
– -$147K -26,510 Closed
JP Morgan Chase
40
JP Morgan Chase
New York
– -$146K -26,395 Closed
Millennium Management
41
Millennium Management
New York
– -$73K -13,089 Closed
MWNA
42
Marshall Wace North America
New York
– -$48K -8,612 Closed
TRCT
43
Tower Research Capital (TRC)
New York
– -$6K -1,200 Closed
PCM
44
Prelude Capital Management
New York
– -$1K -260 Closed
Bank of America
45
Bank of America
North Carolina
– -$1K -99 Closed
1
2

CEMI Hedge Fund Activity: Q2 2019 in Review

38 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q2 2019, worth a combined $44.2M — up 19% from $37.3M a quarter earlier.

Fund positioning in CEMI was balanced in Q2 2019: 7 funds opened new positions, 7 closed out, 10 added to existing stakes and 8 trimmed.

The largest buyer was Roubaix Capital, opening a new position worth an estimated $1.1M. The largest seller was Millrace Asset Group, cutting an estimated $527K.

  • 38 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q2 2019, down from 39 in Q1 2019.
  • Funds reported $44.2M of Chembio diagnostics, Inc. stock for Q2 2019, up 19% quarter-over-quarter.
  • 7 funds opened new Chembio diagnostics, Inc. positions in Q2 2019 and 7 closed out, a net change of 0 holders.
  • The largest Chembio diagnostics, Inc. buyer in Q2 2019 was Roubaix Capital, an estimated $1.1M added.
  • The largest Chembio diagnostics, Inc. seller in Q2 2019 was Millrace Asset Group, an estimated $527K sold.

Based on aggregated 13F filings for Q2 2019.